CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer

Monique C. de Jong, Jimmy Pramana, Jacqueline E. van der Wal, Martin Lacko, Carine J. Peutz-Kootstra, Jos M. de Jong, Robert P. Takes, Johannes H. A. M. Kaanders, Bernard F. van der Laan, Jasper Wachters, Jeroen C. Jansen, Coen R. Rasch, Marie-Louise F. van Velthuysen, Reidar Grenman, Frank J. Hoebers, Ed Schuuring, Michiel W. M. van den Brekel, Adrian C. Begg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)5329-5338
JournalClinical Cancer Research
Volume16
Issue number21
DOIs
Publication statusPublished - 1 Nov 2010

Cite this

de Jong, M. C., Pramana, J., van der Wal, J. E., Lacko, M., Peutz-Kootstra, C. J., de Jong, J. M., Takes, R. P., Kaanders, J. H. A. M., van der Laan, B. F., Wachters, J., Jansen, J. C., Rasch, C. R., van Velthuysen, M-L. F., Grenman, R., Hoebers, F. J., Schuuring, E., van den Brekel, M. W. M., & Begg, A. C. (2010). CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer. Clinical Cancer Research, 16(21), 5329-5338. https://doi.org/10.1158/1078-0432.CCR-10-0799